How much funding has Metabolomic Diagnostics raised?

Metabolomic Diagnostics has raised $4.3M in total funding, most recently a Grant round.

Who are Metabolomic Diagnostics's investors?

Metabolomic Diagnostics's investors include SOSV, EU Horizon 2020.

When was Metabolomic Diagnostics founded?

Metabolomic Diagnostics was founded in 2011.

Where is Metabolomic Diagnostics headquartered?

Metabolomic Diagnostics is headquartered in Little Island, Ireland.

What industry is Metabolomic Diagnostics in?

Metabolomic Diagnostics operates in Biotech, Healthcare.

How many employees does Metabolomic Diagnostics have?

Metabolomic Diagnostics has 11-50 employees.

Metabolomic Diagnostics

Improving Pregnancy Outcomes Globally

Little Island, Ireland · Founded 2011 · $4.3M raised

Biotech

Healthcare

Headquarters: Little Island
Employees: 11–50
Founded: 2011
Business Model: B2B

Website: metabolomicdiagnostics.com
Total Funding: $4.3M
Last Round: $2.2M GrantMay 2018
Rounds: 3

About

Metabolomic Diagnostics is a deep-tech company developing novel biomarker-based diagnostic solutions for complex diseases in pregnancy. The company's primary focus is an early-pregnancy screening test to identify women at risk of preeclampsia, gestational diabetes, and preterm birth, enabling personalized prenatal care. Its pipeline translates metabolomics biomarker panels into clinical laboratory assays.

Summary

Metabolomic Diagnostics is a Biotech company based in Little Island, Ireland, founded in 2011. It has raised $4.3M in total across 3 rounds, most recently a $2.2M Grant round in May 2018. Investors include SOSV and EU Horizon 2020.